Lung Cancer | OncoViews

Watch Other Sessions

Lung Cancer

Therapy Areas

OncoNews

OncoNews

Lung Cancer

Women's Cancers

Urogenital

Gastro-intestinal

Hematology

Other Tumors

Search for:

Videos

Lung Cancer by Solange Peters

Lung Cancer 2024 REVIEW

} 1 h 43 min

Early NSCLC by Jean Yannis Perentes

EARLY NSCLC

} 1 h 37 min

ADCs by Alessandra Curioni

Antibody Drug Conjugates

Antibody Drug Conjugates

} 1 h 39 min

OncoViews on Lung Cancer by Alfredo Addeo

Lung Cancer (ASCO 2024)

} 1 h 32 min

HER2 Session by Ilaria Colombo

HER2 in Lung, GYNE & GI Cancers

} 1 h 34 min

Biomarker Session by Sabina Berezowska

Biomarkers in GI & Lung

} 1 h 45 min

NSCLC Session by Isabelle Opitz

Early NSCLC

} 1 h 30 min

Lung Cancer Session by Solange Peters

Lung Cancer 2023 Review

} 1 h 34 min

ADC Session by Alfredo Addeo

Antibody Drug Conjugates

ADC in Breast, GU & Lung

} 1 h 31 min

Lung Cancer Session by Alfredo Addeo

Lung Cancer (ASCO 2023)

} 1 h 36 min

Articles

Intravenous Drip

Lung Cancer, Women's Cancers

CHMP Recommends Approval of Three Promising Therapies in the EU

Nuria María Novoa

Nuria Aaria Novoa

Surgical Treatment of Lung Cancer: Defining Resectability in the Immunotherapy Era

Debate: Continuous Vs. Fixed-duration Immunotherapy

Intravenous Drip

FDA Approves New Therapies For NSCLC and SCLC

Blue Drug Capsules

Swissmedic Approves Osimertinib for Locally Advanced EGFR-Positive NSCLC

Intravenous Drip

Lung Cancer, Urogenital

European Commission Approves New Treatments for Urothelial and Lung Cancer

Celebrating Breakthroughs in Lung Cancer Treatment on World Lung Cancer Day

White drug capsules

Swissmedic Approves Alectinib In Early Stage ALK+ NSCLC

Swissmedic Approves Durvalumab for Perioperative Treatment of Resectable NSCLC

Alectinib Monotherapy Approved by the European Commission for ALK-Positive NSCLC

Quick Links

Twitter

LinkedIn

Contact

Terms Of Use

Privacy Policy

Legal Notice

Our Partners

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

View preferences

{title} {title} {title}